WallStreetZenWallStreetZen

NASDAQ: ATYR
Atyr Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ATYR past revenue growth

How has ATYR's revenue growth performed historically?
Company
-94.34%
Industry
73.85%
Market
17.39%
ATYR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATYR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ATYR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ATYR earnings and revenue history

Current Revenue
$588.0k
Current Earnings
-$57.9M
Current Profit Margin
-9,846.4%

ATYR Return on Equity

Current Company
-65.2%
Current Industry
22.9%
Current Market
33.8%
ATYR's Return on Equity (-65.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATYR announces earnings.

ATYR Return on Assets

Current Company
-49.8%
Current Industry
3.5%
ATYR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATYR Return on Capital Employed

Current Company
-61.53%
Current Industry
21.4%
ATYR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATYR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATYR$588.00k-$55.34M-$57.90M+44.29%N/A
QSI$1.70M-$82.99M-$89.35M+270.81%N/A
RPTX$68.68M-$79.44M-$68.52M+489.68%N/A
VIGL$0.00-$82.01M-$83.84MN/AN/A
IPSC$2.04M-$117.82M-$131.39M-8.78%N/A
View Top Biotech Stocks

ATYR earnings dates

Next earnings date
Nov 7, 2024

Atyr Pharma Earnings & Revenue FAQ

What were ATYR's earnings last quarter?

On Invalid Date, Atyr Pharma (NASDAQ: ATYR) reported Q2 2024 earnings per share (EPS) of -$0.23, up 4.55% year over year. Total Atyr Pharma earnings for the quarter were -$16.31 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Atyr Pharma stock.

What was ATYR's earnings growth in the past year?

As of Q3 2024, Atyr Pharma's earnings has grown year over year. Atyr Pharma's earnings in the past year totalled -$57.90 million.

What is ATYR's earnings date?

Atyr Pharma's earnings date is Invalid Date. Add ATYR to your watchlist to be reminded of ATYR's next earnings announcement.

What was ATYR's revenue last quarter?

On Invalid Date, Atyr Pharma (NASDAQ: ATYR) reported Q2 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Atyr Pharma's revenue was $0.00.

What was ATYR's revenue growth in the past year?

As of Q3 2024, Atyr Pharma's revenue has grown -94.34% year over year. This is 168.19 percentage points lower than the US Biotechnology industry revenue growth rate of 73.85%. Atyr Pharma's revenue in the past year totalled $588.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.